Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Vous n'êtes pas connecté
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.
Globe Life (GL) stands to gain from solid performance in its Life Insurance and Health Insurance segments, strong liquidity position and favorable...
AZUL's top line is bolstered by an uptick in air travel demand. However, low liquidity is a major headwind.
Golar LNG's (GLNG) shareholder-friendly approach bodes well for the company. However, GLNG is grappling with a surge in vessel operating expenses.
Boyd Gaming (BYD) invests in property upgrades and renovations across its portfolio to drive long-term growth. However, inflationary pressures are a...
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
FedEx's (FDX) bottom line is bolstered by reduced structural cost initiatives. Efforts to reward shareholders are commendable. However, FedEx grapples...